Literature DB >> 16912130

Identification of three novel mutations in the GATA3 gene responsible for familial hypoparathyroidism and deafness in the Chinese population.

Wei-Yih Chiu1, Huan-Wen Chen, Hwei-Wen Chao, Lee-Tzong Yann, Keh-Sung Tsai.   

Abstract

BACKGROUND: Familial hypoparathyroidism may be caused by mutations of several genes. The CaSR and GATA3 genes are the two candidates most commonly responsible for this condition.
OBJECTIVES: We collected five unrelated families with familial hypoparathyroidism and examined their CaSR and GATA3 genes.
METHODS: Blood samples from these five families and 50 ethnically matched unrelated controls were acquired. Biochemistry screening and formal audiogram were performed to evaluate the affected individuals. All the exons and exon-intron boundaries of the GATA3 and CaSR genes were sequenced.
RESULTS: We identified three novel mutations in the GATA3 gene responsible for familial hypoparathyroidism and deafness: 1) a frameshift deletion occurring in codon 160 (478delG) was hypothesized to disrupt dual zinc fingers as well as one transactivating domain; 2) a donor splice site mutation at exon 4/intron 4 boundary (IVS4 + 2 T to GCTTACTTCCC) was predicted to lead to truncated GATA3 proteins that lack both N- and C-terminal zinc-containing fingers; and 3) a missense mutation R353S was predicted to disrupt the helical turn and thus changed the angle between the C-terminal zinc finger and the adjacent C-terminal tail. Except for a previously described polymorphism, G990R, we did not find any genetic variants in the CaSR gene.
CONCLUSIONS: This is the first article presenting mutations of the GATA3 gene responsible for familial hypoparathyroidism and deafness in the Chinese population. Our results expand the spectrum of mutations and report the first splice donor site mutation of the GATA3 gene. In contrast, we do not find causal sequence variants of the CaSR gene from our collection of familial hypoparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16912130     DOI: 10.1210/jc.2006-0864

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

Review 1.  Role of the GATA family of transcription factors in endocrine development, function, and disease.

Authors:  Robert S Viger; Séverine Mazaud Guittot; Mikko Anttonen; David B Wilson; Markku Heikinheimo
Journal:  Mol Endocrinol       Date:  2008-01-03

2.  Renal phenotypic variability in HDR syndrome: glomerular nephropathy as a novel finding.

Authors:  Alexis Chenouard; Bertrand Isidor; Emma Allain-Launay; Anne Moreau; Marc Le Bideau; Gwenaelle Roussey
Journal:  Eur J Pediatr       Date:  2012-10-05       Impact factor: 3.183

3.  Novel dominant-negative mutant of GATA3 in HDR syndrome.

Authors:  Masaaki Ohta; Minenori Eguchi-Ishimae; Mayumi Ohshima; Hidehiko Iwabuki; Koji Takemoto; Kikuko Murao; Toshiyuki Chisaka; Eiichi Yamamoto; Takashi Higaki; Keiichi Isoyama; Mariko Eguchi; Eiichi Ishii
Journal:  J Mol Med (Berl)       Date:  2010-12-01       Impact factor: 4.599

4.  Autosomal dominant hypocalcemia caused by an activating mutation of the calcium-sensing receptor gene: the first case report in Korea.

Authors:  Mi Yeon Kim; Alice Hyun Kyung Tan; Chang-Seok Ki; Ji In Lee; Hye Won Jang; Hyun Won Shin; Sun Wook Kim; Yong-Ki Min; Myung-Shik Lee; Moon-Kyu Lee; Kwang-Won Kim; Jae Hoon Chung
Journal:  J Korean Med Sci       Date:  2010-01-19       Impact factor: 2.153

5.  Hypoparathyroidism, sensorineural deafness, and renal dysgenesis syndrome with a GATA3 mutation.

Authors:  Yong Suk Shim; Woohyeok Choi; Il Tae Hwang; Seung Yang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2015-03-31

6.  A novel loss-of-function mutation of GATA3 (p.R299Q) in a Japanese family with Hypoparathyroidism, Deafness, and Renal Dysplasia (HDR) syndrome.

Authors:  Tetsuji Okawa; Masanori Yoshida; Takeshi Usui; Takahiro Kudou; Yasumasa Iwasaki; Kazuki Fukuoka; Norio Takahashi; Yuka Uehara; Yutaka Oiso
Journal:  BMC Endocr Disord       Date:  2015-10-30       Impact factor: 2.763

7.  Clinical description of a neonate carrying the largest reported deletion involving the 10p15.3p13 region.

Authors:  Saet Byeol Kim; Young-Eun Kim; Ji Mi Jung; Hye Young Jin; Yun-Jung Lim; Mi Lim Chung
Journal:  Clin Case Rep       Date:  2017-07-11

8.  Clinical Auditory Phenotypes Associated with GATA3 Gene Mutations in Familial Hypoparathyroidism-deafness-renal Dysplasia Syndrome.

Authors:  Li Wang; Qiong-Fen Lin; Hong-Yang Wang; Jing Guan; Lan Lan; Lin-Yi Xie; Lan Yu; Ju Yang; Cui Zhao; Jin-Long Liang; Han-Lin Zhou; Huan-Ming Yang; Wen-Ping Xiong; Qiu-Jing Zhang; Da-Yong Wang; Qiu-Ju Wang
Journal:  Chin Med J (Engl)       Date:  2017-03-20       Impact factor: 2.628

9.  Mutational signatures in GATA3 transcription factor and its DNA binding domain that stimulate breast cancer and HDR syndrome.

Authors:  Atlal El-Assaad; Zaher Dawy; Athar Khalil; Georges Nemer
Journal:  Sci Rep       Date:  2021-11-23       Impact factor: 4.379

10.  Novel splice site mutation in GATA3 in a patient with HDR syndrome.

Authors:  Kumihiro Matsuo; Arisa Kobayashi; Yusuke Tanahashi; Satoko Maruyama; Yoshihiro Niitsu; Hidenori Katsuta; Akiko Furuya; Shigeru Suzuki; Mitsunobu Kawamura; Hiroshi Azuma
Journal:  Clin Pediatr Endocrinol       Date:  2017-09-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.